Haleon plc (NYSE:HLN) Given Average Recommendation of “Moderate Buy” by Brokerages

Haleon plc (NYSE:HLN) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $10.95.

A number of brokerages recently weighed in on HLN. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th.

Institutional Investors Weigh In On Haleon

A number of institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its holdings in Haleon by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,007,458 shares of the company’s stock valued at $8,322,000 after acquiring an additional 24,673 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in shares of Haleon by 12.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 13,281 shares of the company’s stock valued at $110,000 after purchasing an additional 1,450 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in shares of Haleon in the 2nd quarter valued at $1,658,000. GAMMA Investing LLC raised its stake in Haleon by 49.7% during the third quarter. GAMMA Investing LLC now owns 15,043 shares of the company’s stock worth $159,000 after buying an additional 4,992 shares during the last quarter. Finally, Atomi Financial Group Inc. boosted its position in Haleon by 48.3% during the third quarter. Atomi Financial Group Inc. now owns 22,518 shares of the company’s stock valued at $238,000 after acquiring an additional 7,330 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.55 on Wednesday. Haleon has a one year low of $7.89 and a one year high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market cap of $43.21 billion, a price-to-earnings ratio of 28.07, a PEG ratio of 2.70 and a beta of 0.28. The firm has a 50 day simple moving average of $9.53 and a 200 day simple moving average of $9.79.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.